FY2025 · period end Dec '25 · from the 10-K filed Mar 31, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.02B | $0.02B | $0.03B | $0.03B | $0.02B |
| Gross Profit | — | — | — | negative: -$0.01B | $0.00B |
| Operating Income | negative: -$0.01B | negative: -$0.04B | negative: -$0.05B | negative: -$0.03B | negative: -$0.02B |
| Net Income | negative: -$0.02B | negative: -$0.05B | negative: -$0.06B | negative: -$0.06B | negative: -$0.03B |
| EPS (Diluted) | — | negative: -$6.63 | negative: -$8.20 | negative: -$0.55 | negative: -$0.70 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.07B | $0.11B | $0.15B | $0.25B | $0.28B |
| Total Liabilities | $0.06B | $0.07B | — | — | — |
| Stockholders' Equity | $0.01B | $0.03B | $0.08B | $0.16B | $0.20B |
| Cash & Equivalents | $0.01B | $0.01B | $0.01B | $0.02B | $0.06B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.01B | negative: -$0.01B | negative: -$0.02B | negative: -$0.03B | negative: -$0.01B |
| Capital Expenditures | — | $0.00B | $0.00B | $0.00B | $0.01B |
| Free Cash Flow | — | negative: -$0.01B | negative: -$0.02B | negative: -$0.03B | negative: -$0.02B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | negative: -32.0% | 17.0% |
| Operating Margin | negative: -0.7% | negative: -2.2% | negative: -2.0% | negative: -1.1% | negative: -1.2% |
| Net Margin | negative: -1.2% | negative: -2.5% | negative: -2.3% | negative: -2.1% | negative: -1.6% |
| Return on Equity | negative: -115.5% | negative: -80.9% | negative: -50.5% | negative: -33.7% | negative: -24.1% |
| Return on Assets | negative: -27.5% | negative: -36.1% | negative: -30.2% | negative: -22.5% | negative: -17.7% |
| Debt / Equity | 0.66× | 0.07× | 0.66× | 0.37× | 0.30× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001493152-26-038447 | Jun 30, 2026 | Aug 14, 2026 | Aug 14, 2026 20:31 UTC | EDGAR |
| 8-K | 0001493152-26-030115 | Jun 23, 2026 | Jun 25, 2026 | Jun 25, 2026 20:05 UTC | EDGAR |
| 10-Q | 0001493152-26-023865 | Mar 31, 2026 | May 15, 2026 | May 15, 2026 20:32 UTC | EDGAR |
| 10-K | 0001493152-26-014231 | Dec 31, 2025 | Mar 31, 2026 | Mar 31, 2026 20:30 UTC | EDGAR |
| 8-K | 0001493152-26-014289 | Mar 26, 2026 | Mar 31, 2026 | Mar 31, 2026 21:00 UTC | EDGAR |
| 8-K | 0001493152-26-005381 | Feb 4, 2026 | Feb 5, 2026 | Feb 5, 2026 22:06 UTC | EDGAR |
| 8-K | 0001493152-25-026231 | Dec 3, 2025 | Dec 5, 2025 | Dec 4, 2025 23:19 UTC | EDGAR |
| 10-Q | 0001493152-25-023374 | Sep 30, 2025 | Nov 14, 2025 | Nov 14, 2025 20:48 UTC | EDGAR |
Direct links to SEC EDGAR. DSS has additional filings available on the SEC site.
6 numbers DSS, INC. later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·FY 2023
Major restatementwas-$21.5M
Revised down in a 10-K.
Revenues·FY 2017
Major restatementwas$18.7M
Revised down in a 10-K. Any P/S built on the original was 1040.7% too low.
Revenues·Q3 2017
Major restatementwas$4.2M
Revised down in a 10-Q. Any P/S built on the original was 874.2% too low.
Revenues·Q1 2018
Major restatementwas$4.4M
Revised down in a 10-Q. Any P/S built on the original was 862.1% too low.
Revenues·Q2 2017
Major restatementwas$3.9M
Revised down in a 10-Q. Any P/S built on the original was 707.6% too low.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2020
Major restatementwas$1.3M
Revised down in a 10-K/A.
DSS is not the only one.
See every restatement we've found across the market — or get an alert the next time DSS revises a number.
Restatements are detected by comparing every vintage of a fact across all of DSS, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows DSS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling DSS, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on DSS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on DSS and publish the result to your public profile.
Ask about DSS, INC.
Continue in Workspace — cited answers on DSS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs